PharmaCyte Biotech, Inc. (PMCB) Net Income by Year
PharmaCyte Biotech, Inc. reported a net loss of $19.4M in fiscal year 2026. This represents a decrease of 163.4% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters PharmaCyte Biotech, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PMCB Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$19.4M-163.4% | $30.7M+9085.0% | $334K+107.7% | -$4.3M-1.8% | -$4.2M-19.4% | -$3.6M+7.2% | -$3.8M+5.9% | -$4.1M+40.4% | -$6.8M-53.7% | -$4.4M+26.7% | -$6.1M+38.9% | -$9.9M+63.6% | -$27.3M-1605.4% | -$1.6M+15.9% | -$1.9M |
PMCB Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More PharmaCyte Biotech, Inc. financials
Frequently Asked Questions
What was PharmaCyte Biotech, Inc.'s net income in fiscal year 2026?
PharmaCyte Biotech, Inc. reported a net loss of $19.4M in fiscal year 2026.
How fast is PharmaCyte Biotech, Inc.'s net income growing?
PharmaCyte Biotech, Inc. (PMCB) net income fell by 163.4% year over year, from $30.7M to -$19.4M in fiscal year 2026.
How has PharmaCyte Biotech, Inc.'s net income changed over the years?
Across the 15 fiscal years this page covers, PharmaCyte Biotech, Inc. (PMCB) net income went from -$1.9M in fiscal year 2012 to -$19.4M in fiscal year 2026.
What was PharmaCyte Biotech, Inc.'s net income in the most recent quarter?
PharmaCyte Biotech, Inc. (PMCB) reported -$5.1M in net income in Q1 2027. This represents an increase of 39.2% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what PharmaCyte Biotech, Inc. (PMCB) reported on that line in every period on record.